Isotopia Molecular Imaging
Radioactive Isotopes for Nuclear Therapy
StartupIsotopia Molecular Imaging is a Petah Tikva-based startup in the Health Tech & Life Sciences sector, established in 2007. Radioactive Isotopes for Nuclear Therapy. The company has raised a total of $3.75M across 1 funding round, currently at the Mature stage. Isotopia Molecular Imaging was founded by Eli Shalom, Dr.. Key investors include Metrontario. The company has 51-200 employees. Core technologies: Simulation & Imaging, Biologicals, Molecules.
With $3.75M in total funding, Isotopia Molecular Imaging is a Mature-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageMature
- ProductReleased
- ModelB2B
- Employees51-200
- HQPetah Tikva
- DistrictCenter District
- Last Round$3.75M
- MetrontarioLead
Eli Shalom, Dr.Co-founder & CEO
12 articles covered by sources including www.prnewswire.com,
www.prnewswire.co.uk,
www.businesswire.com,
www.eurekalert.org,
en.globes.co.il.
What does Isotopia Molecular Imaging do?
Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes diagnostic and therapeutic radioactive isotopes and advanced PET and SPECT radiotracers. Its flagship product, the radioisotope Lutetium-177 (both C.A and N.C.A), has attracted considerable attention and exhibited great promise in treating a variety of late-stage cancers, including metastatic prostate cancer and neuroendocrine tumors. Its production facilities include an advanced nuclear pharmacy that provides radionuclide labelled compounds for PET/SPECT imaging, a cyclotron facility, and an aseptic manufacturing plant that also offers contract manufacturing services (CMO).
How much funding has Isotopia Molecular Imaging raised?
Isotopia Molecular Imaging has raised $3.75M in total funding across 1 rounds. The company is currently at the Mature stage. Key investors include Metrontario.
Who founded Isotopia Molecular Imaging?
Isotopia Molecular Imaging was founded in 2007 by Eli Shalom, Dr. (Co-founder & CEO).
What sector is Isotopia Molecular Imaging in?
Isotopia Molecular Imaging operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Simulation & Imaging, Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Healthcare, Life Sciences, Pharmaceuticals, Medical Devices Industry, Medical Equipment.
Where is Isotopia Molecular Imaging located?
Isotopia Molecular Imaging is based in Alexander Yanai Street 39, Petah Tikva, Israel, Center District. The company also has offices abroad.